Studies have shown that ritanserin inhibits C-RAF to cause apoptosis in lung cancer cells and prevents glioblastoma multiforme (GBM) and pancreatic cancer spread by modifying DGKα, which promotes the mesenchymal phenotype [10, 12]. This evidence concerns the gene DGKA and pancreatic neoplasm.